相关实验视频

Updated: Sep 19, 2025

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins

Published on: October 18, 2022

相互激活的双指数放大DNA机器增强了强大的CRISPR/Cas12a反传播,用于超敏感的miRNA检测

Qi Wang¹, Shuo Yang¹, Xiumei Chen¹

¹Key Laboratory of Embryo Development and Reproductive Regulation, Anhui Province Key Laboratory of Pollution Damage and Biological Control for Huaihe River Basin, School of Biological and Food Engineering, Fuyang Normal University, Fuyang, Anhui 236037, P. R. China.

Analytical chemistry

|June 15, 2025

概括

我们开发了一种新的DNA机器,用于对miR-155.5的超敏感乳腺癌 (BC) 检测. 该系统显示出高灵敏度和特异性,通过液体活检帮助早期BC诊断.

科学领域:

生物技术是生物技术.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

乳腺癌 (BC) 是一个主要的全球健康问题.
早期发现像miR-155这样的生物标志物对于有效的BC管理至关重要.
现有的检测方法往往缺乏所需的灵敏度和特异性.

研究的目的:

开发一个超敏感的检测平台,用于miR-155,一个关键的乳腺癌生物标志物.
创建一个相互激活的双放大DNA机器,用于增强信号生成.
通过液体活检建立一个可靠的早期乳腺癌诊断系统.

主要方法:

开发一种相互激活的双指数放大DNA机器 (MADEA-DNA机器).
指数级滚动圆放大 (E-RCA) 和自动催化增量链位移放大 (AI-SDA) 的集成.
使用CRISPR/Cas12a进行光报道器的跨裂变以放大信号.

主要成果:

实现了miR-155.5的1.26 fM的超敏感检测极限.
演示了从5 fM到10 nM的广泛动态范围.
对非标microRNAs表现出高特异性,并在BC患者的人类血清中验证了升高的miR-155水平.

结论:

MADEA-DNA机器为miR-155检测提供了一种高度敏感和特定的方法.
该平台显示了使用液体活检早期诊断乳腺癌的巨大潜力.
双放大策略与CRISPR技术相结合,提高了诊断能力.

更多相关视频

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a

Published on: December 23, 2022

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

相关概念视频

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...